Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Wallstrip: Economic Purgatory
- Will the government's efforts kick in before it's too late?
- Videos 2008-10-28
Additional Resources
- Q&A: Merck's Kevin Nalty, YouTube Star, Explains Why He Quit
- Kevin Nalty was Merck's consumer product director on Propecia until last week when he quit after a series of videos he posted on YouTube drew too much attention to the drug company. The move came after it emerged that he was “Nalts,†the creator of a YouTube video titled “Farting...
- Blog posts 2009-05-27
- With Singulair Threatened, Merck Looks More Like Target Than Acquirer
- Merck CEO Richard Clark made a few headlines when he said in his Q4 conference call that "I wouldn't rule anything out" when it came to large-scale M&A transactions. CEOs always say this sort of vague, noncommittal thing, but in Merck's case it is looking as if...
- Blog posts 2009-02-20
- Merck Executive Pay: $36 million, Use of Private Jet, Cash Bonuses Despite Failures
- The top five executives at Merck took home $36 million in compensation last year. All received cash bonuses of between $563,767 and $2.2 million even though two of them had "below-target performance," according to a Merck filing with the SEC. They also got to use the corporate jet, and so...
- Blog posts 2009-03-06
- New Merck Allegations: A Fake Journal; Ghostwritten Studies; Vioxx Pop Songs; PR Execs Harass Reporters
- Federal prosecutors in the U.S. will be reading with amusement the Australian press's coverage of a class action trial down under for patients who took Merck's now-withdrawn painkiller Vioxx. Details emerging in Oz make some of the antics that Merck's American counterparts got up to look tame...
- Blog posts 2009-04-23
- Merck-Schering Roundup: Layoffs More Likely at Schering; Insiders Traded Fortuitously; How Merck Timed the Deal
- LAYOFFS? In the Merck/Schering-Plough merger, layoffs will likely fall most heavily on the Schering employees. This is not just because Merck is the acquiring company and will place its people in the driving seats. (That, of course, will be part of it.) Rather, it's because Schering has...
- Blog posts 2009-03-10
- J&J vs. Merck and Schering: Who Is Most Desperate in This Bizarre Love Triangle?
- Nobody wants to say anything about the great Remicade tug of war that has broken out between Johnson & Johnson and the soon-to-be-merged Merck and Schering-Plough. A look at the Q1 2009 numbers suggest that each member of this trio has their own reasons to be quietly...
- Blog posts 2009-04-24
- Merck fixes on new structure, management
- As expected, there's a new management line-up at Merck. The drugmaker announced that post-merger with Schering-Plough, it will have five main divisions--global human health, animal health, consumer healthcare, research, and manufacturing--each headed up by a manager reporting directly to CEO Richard Clark. Animal health and consumer health will operate as...
- News items 2009-08-31
- Is Merck Hanging Schering Out to Dry on Vytorin?
- Is Merck Hanging Schering Out to Dry on Vytorin?VytorinPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...
- Discussion threads 2008-07-07
- Johnson & Perkinson Announces Investigation of Merck 401k Retirement Plans
- SOUTH BURLINGTON, Vt. -- The law firm of Johnson & Perkinson is investigating potential claims against Merck & Co., Inc. ("Merck") (NYSE: MRK) by current or former employees who purchased Merck shares through a Merck 401k retirement plan between May 21, 1999 and the present and who may be eligible...
- Research articles 2004-10-01
- Is Merck Hanging Schering Out to Dry on Vytorin?
- A close reading of the Merck and Schering-Plough first-quarter conference calls suggests that Merck is distancing itself from its joint-venture partner -- who is, in any event, in a much worse position to weather the storm over their cholesterol-fighting pill Vytorin. Vytorin, of course, is a combination...
- Blog posts 2008-04-23
- At Merck, Desperation Sets in Over Gardasil
- Signs of decline are setting in at Merck's highly profitable vaccine for some strains of HPV and cervical cancer. Merck has adjusted its marketing to target women who are not the most likely to benefit from it. The drug has seen a 33 percent decline in sales. ...
- Blog posts 2008-10-19
- Gardasil in Decline, Merck Now Increasingly Dependent on Januvia
- Merck CEO Richard Clark says he cannot "categorically rule out" an acquisition despite a slight uptick in net income, according to the WSJ. You bet he can't. A look at Merck's income statement shows that the company is increasingly dependent on a single drug -- diabetes treatment Januvia -- and...
- Blog posts 2009-02-04
- The Arbiter Study Is Another Setback For Merck
- Abbott Labs' Niaspan appeared safer and more effective that Merck's Zetia as a secondary cholesterol treatment, according to a study released Sunday night. Funded by Abbott and called Arbiter-6, the study measured thickness of the carotid artery leading to the brain in 208 patients, who were given simvastatin along with...
- News items 2009-11-15
- Merck.(Merck Manufacturing Div. promotes Willie Deese)(Brief Article)
- Merck's Willie Deese has continued his rise in the pharmaceutical industry, being named president of Merck's manufacturing division recently. Deese joined Merck as senior vice president of global procurement, in January 2004, after nearly three de Merck's Willie Deese has continued his rise...
- Research articles 2005-07-14
- Merck kgaa health business formed. (roundup).(Merck Consumer Health Care Holding GmbH subsidary formed)(Brief Article)
- Merck KGaA has formed a new holding company for its consumer health care business called Merck Consumer Health Care Holding GmbH. The German business, Merck Selbstmedikation GmbH, has been transferred to the holding company while Seven Seas Ltd. (U Merck KGaA has formed a...
- Research articles 2001-11-19
- Merck Opens $400MM Bulk Chemical Plant in Singapore.(Merck Sharp and Dohme)(Brief Article)
- MERCK & CO. Inc.'s subsidiary Merck Sharp & Dohme Ltd. has opened its $400 million, 30-acre bulk chemical manufacturing plant in Singapore. The plant, Merck's first in the Asia-Pacific region, will produce the active ingredient for Vioxx (r MERCK & CO. Inc.'s subsidiary Merck...
- Research articles 2001-09-24
- ISRAEL: MERCK INVESTS IN ISRAELI PHARMACEUTICAL FIRMS.(Merck and Co., biotechnology investment plans in Israel)(Brief Article)
- Merck and Co., one of the world's largest pharmaceutical manufacturers, announced this week that it will invest in Israeli biotechnology companies, GLOBES, reported. Merck has refrained from investing in Israel until now. Merck Israel CEO Yossi Ben-A Merck and Co., one of the world's largest pharmaceutical...
- Research articles 2002-05-27
- Merck's Vaccine Efforts Are Struggling
- Merck seems to be having difficulty with many of its vaccine efforts. So much so that CEO Richard Clark all but apologized to analysts in his third quarter earnings call. The trouble began about a year ago, when Merck recalled a batch of Pedvaxhib and Comvax vaccines, for Haemophilius influenzae...
- Blog posts 2008-10-31
- KILL BW1254, NJ-MERCK-MEDCO and KILL BW1449, CQN-NJ-MERCK-MEDCO
- --BUSINESS WIRE-- Please KILL BW1254, (NJ-MERCK-MEDCO)MRK Physicians' Online and Merck-Medco Expand Suite of Internet Applications for Mail Service Prescriptions, which ran on Business Wire at 10:00AM ET on 04/22/1999. Also KILL the CORRECTION, BW1449, (CQN-NJ-MERCK-MEDCO)MRK Merck-Medco Corrects and Replaces Release Issued Earlier Today, BW1254, (NJ-MERCK-MEDCO), which ran on...
- Research articles 2002-04-01
- << Previous
- page 1 of 1
- Next >>
Presented by American Express